| Year |
Citation |
Score |
| 2012 |
Roussos P, Katsel P, Davis KL, Siever LJ, Haroutunian V. A system-level transcriptomic analysis of schizophrenia using postmortem brain tissue samples. Archives of General Psychiatry. 69: 1205-13. PMID 22868662 DOI: 10.1001/Archgenpsychiatry.2012.704 |
0.343 |
|
| 2011 |
Takahashi N, Sakurai T, Bozdagi-Gunal O, Dorr NP, Moy J, Krug L, Gama-Sosa M, Elder GA, Koch RJ, Walker RH, Hof PR, Davis KL, Buxbaum JD. Increased expression of receptor phosphotyrosine phosphatase-β/ζ is associated with molecular, cellular, behavioral and cognitive schizophrenia phenotypes. Translational Psychiatry. 1: e8. PMID 22832403 DOI: 10.1038/Tp.2011.8 |
0.36 |
|
| 2011 |
Tang CY, Friedman JI, Carpenter DM, Novakovic V, Eaves E, Ng J, Wu YW, Gottlieb S, Wallenstein S, Moshier E, Parrella M, White L, Bowler S, McGinn TG, Flanagan L, ... Davis KL, et al. The effects of hypertension and body mass index on diffusion tensor imaging in schizophrenia. Schizophrenia Research. 130: 94-100. PMID 21641187 DOI: 10.1016/J.Schres.2011.05.002 |
0.322 |
|
| 2011 |
Radu A, Hristescu G, Katsel P, Haroutunian V, Davis KL. Microarray database mining and cell differentiation defects in schizophrenia. Advances in Experimental Medicine and Biology. 696: 67-74. PMID 21431547 DOI: 10.1007/978-1-4419-7046-6_7 |
0.317 |
|
| 2011 |
Friedman JI, Lindenmayer JP, Alcantara F, Bowler S, Parak M, White L, Iskander A, Parrella M, Adler DN, Tsopelas ND, Tsai WY, Novakovic V, Novakovick V, Harvey PD, Davis KL, et al. Pimozide augmentation of clozapine inpatients with schizophrenia and schizoaffective disorder unresponsive to clozapine monotherapy. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 36: 1289-95. PMID 21346734 DOI: 10.1038/Npp.2011.14 |
0.341 |
|
| 2011 |
Takahashi N, Sakurai T, Davis KL, Buxbaum JD. Linking oligodendrocyte and myelin dysfunction to neurocircuitry abnormalities in schizophrenia. Progress in Neurobiology. 93: 13-24. PMID 20950668 DOI: 10.1016/J.Pneurobio.2010.09.004 |
0.352 |
|
| 2010 |
De Gasperi R, Gama Sosa MA, Naumowicz Z, Hof PR, Notterpek L, Davis KL, Buxbaum JD, Elder GA. PERIPHERAL MYELIN PROTEIN-22 IS EXPRESSED IN CNS MYELIN. Translational Neuroscience. 1: 282-285. PMID 21572910 DOI: 10.2478/V10134-010-0038-3 |
0.31 |
|
| 2010 |
Friedman JI, Wallenstein S, Moshier E, Parrella M, White L, Bowler S, Gottlieb S, Harvey PD, McGinn TG, Flanagan L, Davis KL. The effects of hypertension and body mass index on cognition in schizophrenia. The American Journal of Psychiatry. 167: 1232-9. PMID 20634363 DOI: 10.1176/Appi.Ajp.2010.09091328 |
0.343 |
|
| 2010 |
Glessner JT, Reilly MP, Kim CE, Takahashi N, Albano A, Hou C, Bradfield JP, Zhang H, Sleiman PM, Flory JH, Imielinski M, Frackelton EC, Chiavacci R, Thomas KA, Garris M, ... ... Davis KL, et al. Strong synaptic transmission impact by copy number variations in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 107: 10584-9. PMID 20489179 DOI: 10.1073/Pnas.1000274107 |
0.343 |
|
| 2008 |
Carpenter DM, Tang CY, Friedman JI, Hof PR, Stewart DG, Buchsbaum MS, Harvey PD, Gorman JG, Davis KL. Temporal characteristics of tract-specific anisotropy abnormalities in schizophrenia. Neuroreport. 19: 1369-72. PMID 18766013 DOI: 10.1097/Wnr.0B013E32830Abc35 |
0.362 |
|
| 2008 |
Friedman JI, Tang C, Carpenter D, Buchsbaum M, Schmeidler J, Flanagan L, Golembo S, Kanellopoulou I, Ng J, Hof PR, Harvey PD, Tsopelas ND, Stewart D, Davis KL. Diffusion tensor imaging findings in first-episode and chronic schizophrenia patients. The American Journal of Psychiatry. 165: 1024-32. PMID 18558643 DOI: 10.1176/Appi.Ajp.2008.07101640 |
0.365 |
|
| 2008 |
Buxbaum JD, Georgieva L, Young JJ, Plescia C, Kajiwara Y, Jiang Y, Moskvina V, Norton N, Peirce T, Williams H, Craddock NJ, Carroll L, Corfas G, Davis KL, Owen MJ, et al. Molecular dissection of NRG1-ERBB4 signaling implicates PTPRZ1 as a potential schizophrenia susceptibility gene. Molecular Psychiatry. 13: 162-72. PMID 17579610 DOI: 10.1038/Sj.Mp.4001991 |
0.322 |
|
| 2007 |
Chang L, Friedman J, Ernst T, Zhong K, Tsopelas ND, Davis K. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biological Psychiatry. 62: 1396-404. PMID 17693392 DOI: 10.1016/J.Biopsych.2007.05.025 |
0.362 |
|
| 2007 |
Haroutunian V, Davis KL. Introduction to the special section: Myelin and oligodendrocyte abnormalities in schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 499-502. PMID 17583597 DOI: 10.1017/S1461145706007449 |
0.332 |
|
| 2007 |
Haroutunian V, Katsel P, Dracheva S, Stewart DG, Davis KL. Variations in oligodendrocyte-related gene expression across multiple cortical regions: implications for the pathophysiology of schizophrenia. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 10: 565-73. PMID 17291370 DOI: 10.1017/S1461145706007310 |
0.333 |
|
| 2007 |
McCullumsmith RE, Gupta D, Beneyto M, Kreger E, Haroutunian V, Davis KL, Meador-Woodruff JH. Expression of transcripts for myelination-related genes in the anterior cingulate cortex in schizophrenia. Schizophrenia Research. 90: 15-27. PMID 17223013 DOI: 10.1016/J.Schres.2006.11.017 |
0.304 |
|
| 2006 |
Haroutunian V, Katsel P, Dracheva S, Davis KL. The human homolog of the QKI gene affected in the severe dysmyelination "quaking" mouse phenotype: downregulated in multiple brain regions in schizophrenia. The American Journal of Psychiatry. 163: 1834-7. PMID 17012699 DOI: 10.1176/Ajp.2006.163.10.1834 |
0.355 |
|
| 2006 |
Friedman JI, Davis KL. Special issue: Molecular mechanisms of schizophrenia. Biological Psychiatry. 60: 527-9. PMID 16996999 DOI: 10.1016/J.Biopsych.2006.08.010 |
0.32 |
|
| 2006 |
White L, Friedman JI, Bowie CR, Evers M, Harvey PD, Parrella M, Mihaila E, Davis KL. Long-term outcomes in chronically hospitalized geriatric patients with schizophrenia: retrospective comparison of first generation and second generation antipsychotics. Schizophrenia Research. 88: 127-34. PMID 16926093 DOI: 10.1016/J.Schres.2006.06.038 |
0.346 |
|
| 2006 |
Georgieva L, Moskvina V, Peirce T, Norton N, Bray NJ, Jones L, Holmans P, Macgregor S, Zammit S, Wilkinson J, Williams H, Nikolov I, Williams N, Ivanov D, Davis KL, et al. Convergent evidence that oligodendrocyte lineage transcription factor 2 (OLIG2) and interacting genes influence susceptibility to schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 103: 12469-74. PMID 16891421 DOI: 10.1073/Pnas.0603029103 |
0.307 |
|
| 2006 |
Carrión-Baralt JR, Smith CJ, Rossy-Fullana E, Lewis-Fernández R, Davis KL, Silverman JM. Seasonality effects on schizophrenic births in multiplex families in a tropical island. Psychiatry Research. 142: 93-7. PMID 16516305 DOI: 10.1016/J.Psychres.2004.04.017 |
0.339 |
|
| 2006 |
Harvey PD, Friedman JI, Bowie C, Reichenberg A, McGurk SR, Parrella M, White L, Davis KL. Validity and stability of performance-based estimates of premorbid educational functioning in older patients with schizophrenia. Journal of Clinical and Experimental Neuropsychology. 28: 178-92. PMID 16484092 DOI: 10.1080/13803390500360349 |
0.308 |
|
| 2006 |
Prohovnik I, Perl DP, Davis KL, Libow L, Lesser G, Haroutunian V. Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease. Neurology. 66: 49-55. PMID 16401845 DOI: 10.1212/01.Wnl.0000191298.68045.50 |
0.311 |
|
| 2006 |
Dracheva S, Davis KL, Chin B, Woo DA, Schmeidler J, Haroutunian V. Myelin-associated mRNA and protein expression deficits in the anterior cingulate cortex and hippocampus in elderly schizophrenia patients. Neurobiology of Disease. 21: 531-40. PMID 16213148 DOI: 10.1016/J.Nbd.2005.08.012 |
0.343 |
|
| 2005 |
Clinton SM, Ibrahim HM, Frey KA, Davis KL, Haroutunian V, Meador-Woodruff JH. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin. The American Journal of Psychiatry. 162: 1859-71. PMID 16199832 DOI: 10.1176/Appi.Ajp.162.10.1859 |
0.327 |
|
| 2005 |
Gupta DS, McCullumsmith RE, Beneyto M, Haroutunian V, Davis KL, Meador-Woodruff JH. Metabotropic glutamate receptor protein expression in the prefrontal cortex and striatum in schizophrenia. Synapse (New York, N.Y.). 57: 123-31. PMID 15945063 DOI: 10.1002/Syn.20164 |
0.331 |
|
| 2005 |
Katsel P, Davis KL, Gorman JM, Haroutunian V. Variations in differential gene expression patterns across multiple brain regions in schizophrenia. Schizophrenia Research. 77: 241-52. PMID 15923110 DOI: 10.1016/J.Schres.2005.03.020 |
0.313 |
|
| 2005 |
Friedman JI, Ocampo R, Elbaz Z, Parrella M, White L, Bowler S, Davis KL, Harvey PD. The effect of citalopram adjunctive treatment added to atypical antipsychotic medications for cognitive performance in patients with schizophrenia. Journal of Clinical Psychopharmacology. 25: 237-42. PMID 15876902 DOI: 10.1097/01.Jcp.0000161499.58266.51 |
0.367 |
|
| 2005 |
Bruneau EG, McCullumsmith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Increased expression of glutaminase and glutamine synthetase mRNA in the thalamus in schizophrenia. Schizophrenia Research. 75: 27-34. PMID 15820321 DOI: 10.1016/J.Schres.2004.12.012 |
0.331 |
|
| 2005 |
Katsel PL, Davis KL, Haroutunian V. Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. International Review of Neurobiology. 63: 41-82. PMID 15797465 DOI: 10.1016/S0074-7742(05)63003-6 |
0.312 |
|
| 2004 |
Bubber P, Tang J, Haroutunian V, Xu H, Davis KL, Blass JP, Gibson GE. Mitochondrial enzymes in schizophrenia. Journal of Molecular Neuroscience : Mn. 24: 315-21. PMID 15456945 DOI: 10.1385/Jmn:24:2:315 |
0.349 |
|
| 2004 |
McGurk SR, Coleman T, Harvey PD, Reichenberg A, White L, Friedman J, Parrella M, Davis KL. Working memory performance in poor outcome schizophrenia: relationship to age and executive functioning. Journal of Clinical and Experimental Neuropsychology. 26: 153-60. PMID 15202535 DOI: 10.1076/Jcen.26.2.153.28079 |
0.303 |
|
| 2004 |
Dracheva S, Elhakem SL, McGurk SR, Davis KL, Haroutunian V. GAD67 and GAD65 mRNA and protein expression in cerebrocortical regions of elderly patients with schizophrenia. Journal of Neuroscience Research. 76: 581-92. PMID 15114630 DOI: 10.1002/Jnr.20122 |
0.317 |
|
| 2004 |
Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Davis KL. A comprehensive analysis of verbal fluency deficit in geriatric schizophrenia. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 19: 289-303. PMID 15010092 DOI: 10.1016/S0887-6177(03)00041-6 |
0.384 |
|
| 2004 |
Stewart DG, Davis KL. Possible contributions of myelin and oligodendrocyte dysfunction to schizophrenia. International Review of Neurobiology. 59: 381-424. PMID 15006496 DOI: 10.1016/S0074-7742(04)59015-3 |
0.321 |
|
| 2004 |
Siever LJ, Davis KL. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. The American Journal of Psychiatry. 161: 398-413. PMID 14992962 DOI: 10.1176/Appi.Ajp.161.3.398 |
0.36 |
|
| 2004 |
Mueller HT, Haroutunian V, Davis KL, Meador-Woodruff JH. Expression of the ionotropic glutamate receptor subunits and NMDA receptor-associated intracellular proteins in the substantia nigra in schizophrenia. Brain Research. Molecular Brain Research. 121: 60-9. PMID 14969737 DOI: 10.1016/J.Molbrainres.2003.11.004 |
0.307 |
|
| 2003 |
Martin-Ruiz CM, Haroutunian VH, Long P, Young AH, Davis KL, Perry EK, Court JA. Dementia rating and nicotinic receptor expression in the prefrontal cortex in schizophrenia. Biological Psychiatry. 54: 1222-33. PMID 14643090 DOI: 10.1016/S0006-3223(03)00348-2 |
0.363 |
|
| 2003 |
Harvey PD, Bertisch H, Friedman JI, Marcus S, Parrella M, White L, Davis KL. The course of functional decline in geriatric patients with schizophrenia: cognitive-functional and clinical symptoms as determinants of change. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 610-9. PMID 14609801 DOI: 10.1176/Appi.Ajgp.11.6.610 |
0.327 |
|
| 2003 |
Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, Davis K. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophrenia Research. 64: 53-62. PMID 14511801 DOI: 10.1016/S0920-9964(02)00526-1 |
0.36 |
|
| 2003 |
Davis KL, Haroutunian V. Global expression-profiling studies and oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet. 362: 758. PMID 13678867 DOI: 10.1016/S0140-6736(03)14297-3 |
0.328 |
|
| 2003 |
Polesskaya OO, Haroutunian V, Davis KL, Hernandez I, Sokolov BP. Novel putative nonprotein-coding RNA gene from 11q14 displays decreased expression in brains of patients with schizophrenia. Journal of Neuroscience Research. 74: 111-22. PMID 13130513 DOI: 10.1002/Jnr.10752 |
0.346 |
|
| 2003 |
Hof PR, Haroutunian V, Friedrich VL, Byne W, Buitron C, Perl DP, Davis KL. Loss and altered spatial distribution of oligodendrocytes in the superior frontal gyrus in schizophrenia. Biological Psychiatry. 53: 1075-85. PMID 12814859 DOI: 10.1016/S0006-3223(03)00237-3 |
0.326 |
|
| 2003 |
Aisen PS, Schafer KA, Grundman M, Pfeiffer E, Sano M, Davis KL, Farlow MR, Jin S, Thomas RG, Thal LJ. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. Jama. 289: 2819-26. PMID 12783912 DOI: 10.1001/Jama.289.21.2819 |
0.484 |
|
| 2003 |
Davis KL, Stewart DG, Friedman JI, Buchsbaum M, Harvey PD, Hof PR, Buxbaum J, Haroutunian V. White matter changes in schizophrenia: evidence for myelin-related dysfunction. Archives of General Psychiatry. 60: 443-56. PMID 12742865 DOI: 10.1001/Archpsyc.60.5.443 |
0.325 |
|
| 2003 |
Haroutunian V, Dracheva S, Davis KL. Neurobiology of glutamatergic abnormalities in schizophrenia Clinical Neuroscience Research. 3: 67-76. DOI: 10.1016/S1566-2772(03)00020-3 |
0.329 |
|
| 2003 |
Breier A, Keefe RS, Young CA, Purdon SE, Gold JM, Davis KL. A one-year double-blind comparison of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in patients with schizophrenia Schizophrenia Research. 60: 274-275. DOI: 10.1016/S0920-9964(03)80434-6 |
0.479 |
|
| 2002 |
Bowie CR, Harvey PD, Moriarty PJ, Parrella M, White L, Mohs RC, Davis KL. Cognitive assessment of geriatric schizophrenic patients with severe impairment. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 17: 611-23. PMID 14591846 DOI: 10.1016/S0887-6177(01)00165-2 |
0.311 |
|
| 2002 |
Hof PR, Haroutunian V, Copland C, Davis KL, Buxbaum JD. Molecular and cellular evidence for an oligodendrocyte abnormality in schizophrenia. Neurochemical Research. 27: 1193-200. PMID 12462417 DOI: 10.1023/A:1020981510759 |
0.352 |
|
| 2002 |
Friedman JI, Harvey PD, McGurk SR, White L, Parrella M, Raykov T, Coleman T, Adler DN, Davis KL. Correlates of change in functional status of institutionalized geriatric schizophrenic patients: focus on medical comorbidity. The American Journal of Psychiatry. 159: 1388-94. PMID 12153833 DOI: 10.1176/Appi.Ajp.159.8.1388 |
0.357 |
|
| 2002 |
Buchsbaum MS, Shihabuddin L, Hazlett EA, Schröder J, Haznedar MM, Powchik P, Spiegel-Cohen J, Wei T, Singer MB, Davis KL. Kraepelinian and non-Kraepelinian schizophrenia subgroup differences in cerebral metabolic rate. Schizophrenia Research. 55: 25-40. PMID 11955961 DOI: 10.1016/S0920-9964(01)00206-7 |
0.315 |
|
| 2002 |
Harvey PD, Moriarty PJ, Bowie C, Friedman JI, Parrella M, White L, Davis KL. Cortical and subcortical cognitive deficits in schizophrenia: convergence of classifications based on language and memory skill areas. Journal of Clinical and Experimental Neuropsychology. 24: 55-66. PMID 11935424 DOI: 10.1076/Jcen.24.1.55.964 |
0.334 |
|
| 2001 |
Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Vesicular glutamate transporter transcript expression in the thalamus in schizophrenia. Neuroreport. 12: 2885-7. PMID 11588596 DOI: 10.1097/00001756-200109170-00026 |
0.325 |
|
| 2001 |
Friedman JI, Harvey PD, Coleman T, Moriarty PJ, Bowie C, Parrella M, White L, Adler D, Davis KL. Six-year follow-up study of cognitive and functional status across the lifespan in schizophrenia: a comparison with Alzheimer's disease and normal aging. The American Journal of Psychiatry. 158: 1441-8. PMID 11532729 DOI: 10.1176/Appi.Ajp.158.9.1441 |
0.361 |
|
| 2001 |
Dracheva S, Marras SA, Elhakem SL, Kramer FR, Davis KL, Haroutunian V. N-methyl-D-aspartic acid receptor expression in the dorsolateral prefrontal cortex of elderly patients with schizophrenia. The American Journal of Psychiatry. 158: 1400-10. PMID 11532724 DOI: 10.1176/Appi.Ajp.158.9.1400 |
0.331 |
|
| 2001 |
Smith RE, Haroutunian V, Davis KL, Meador-Woodruff JH. Expression of excitatory amino acid transporter transcripts in the thalamus of subjects with schizophrenia. The American Journal of Psychiatry. 158: 1393-9. PMID 11532723 DOI: 10.1176/Appi.Ajp.158.9.1393 |
0.332 |
|
| 2001 |
Friedman JI, Adler DN, Temporini HD, Kemether E, Harvey PD, White L, Parrella M, Davis KL. Guanfacine treatment of cognitive impairment in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 25: 402-9. PMID 11522468 DOI: 10.1016/S0893-133X(01)00249-4 |
0.315 |
|
| 2001 |
Harvey PD, Serper MR, White L, Parrella MJ, McGurk SR, Moriarty PJ, Bowie C, Vadhan N, Friedman J, Davis KL. The convergence of neuropsychological testing and clinical ratings of cognitive impairment in patients with schizophrenia. Comprehensive Psychiatry. 42: 306-13. PMID 11458305 DOI: 10.1053/Comp.2001.24587A |
0.335 |
|
| 2001 |
Hakak Y, Walker JR, Li C, Wong WH, Davis KL, Buxbaum JD, Haroutunian V, Fienberg AA. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 98: 4746-51. PMID 11296301 DOI: 10.1073/Pnas.081071198 |
0.348 |
|
| 2001 |
Meador-Woodruff JH, Davis KL, Haroutunian V. Abnormal kainate receptor expression in prefrontal cortex in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 24: 545-52. PMID 11282254 DOI: 10.1016/S0893-133X(00)00189-5 |
0.308 |
|
| 2001 |
Moriarty PJ, Lieber D, Bennett A, White L, Parrella M, Harvey PD, Davis KL. Gender differences in poor outcome patients with lifelong schizophrenia. Schizophrenia Bulletin. 27: 103-13. PMID 11215540 DOI: 10.1093/Oxfordjournals.Schbul.A006850 |
0.345 |
|
| 2000 |
Ibrahim HM, Hogg AJ, Healy DJ, Haroutunian V, Davis KL, Meador-Woodruff JH. Ionotropic glutamate receptor binding and subunit mRNA expression in thalamic nuclei in schizophrenia. The American Journal of Psychiatry. 157: 1811-23. PMID 11058479 DOI: 10.1176/Appi.Ajp.157.11.1811 |
0.305 |
|
| 2000 |
McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Friedman J, Davis KL. Relationship of cognitive functioning, adaptive life skills, and negative symptom severity in poor-outcome geriatric schizophrenia patients. The Journal of Neuropsychiatry and Clinical Neurosciences. 12: 257-64. PMID 11001606 DOI: 10.1176/Jnp.12.2.257 |
0.304 |
|
| 2000 |
Haroutunian V, Serby M, Purohit DP, Perl DP, Marin D, Lantz M, Mohs RC, Davis KL. Contribution of Lewy body inclusions to dementia in patients with and without Alzheimer disease neuropathological conditions. Archives of Neurology. 57: 1145-50. PMID 10927794 DOI: 10.1001/Archneur.57.8.1145 |
0.312 |
|
| 2000 |
Harvey PD, Moriarty PJ, Friedman JI, White L, Parrella M, Mohs RC, Davis KL. Differential preservation of cognitive functions in geriatric patients with lifelong chronic schizophrenia: less impairment in reading compared with other skill areas. Biological Psychiatry. 47: 962-8. PMID 10838064 DOI: 10.1016/S0006-3223(00)00245-6 |
0.327 |
|
| 2000 |
Harvey PD, Jacobsen H, Mancini D, Parrella M, White L, Haroutunian V, Davis KL. Clinical, cognitive and functional characteristics of long-stay patients with schizophrenia: a comparison of VA and state hospital patients. Schizophrenia Research. 43: 3-9. PMID 10828410 DOI: 10.1016/S0920-9964(99)00182-6 |
0.351 |
|
| 2000 |
McGurk SR, Moriarty PJ, Harvey PD, Parrella M, White L, Davis KL. The longitudinal relationship of clinical symptoms, cognitive functioning, and adaptive life in geriatric schizophrenia. Schizophrenia Research. 42: 47-55. PMID 10706985 DOI: 10.1016/S0920-9964(99)00097-3 |
0.356 |
|
| 2000 |
Aisen PS, Davis KL, Berg JD, Schafer K, Campbell K, Thomas RG, Weiner MF, Farlow MR, Sano M, Grundman M, Thal LJ. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology. 54: 588-93. PMID 10680787 DOI: 10.1212/WNL.54.3.588 |
0.399 |
|
| 2000 |
Richardson-Burns SM, Haroutunian V, Davis KL, Watson SJ, Meador-Woodruff JH. Metabotropic glutamate receptor mRNA expression in the schizophrenic thalamus. Biological Psychiatry. 47: 22-8. PMID 10650445 DOI: 10.1016/S0006-3223(99)00207-3 |
0.316 |
|
| 2000 |
Byne W, Stamu C, White L, Parrella M, Harvey PD, Davis KL. Prevalence and correlates of parkinsonism in an institutionalized population of geriatric patients with chronic schizophrenia. International Journal of Geriatric Psychiatry. 15: 7-13. PMID 10637399 DOI: 10.1002/(Sici)1099-1166(200001)15:1<7::Aid-Gps69>3.0.Co;2-Z |
0.368 |
|
| 2000 |
Meador-Woodruff J, Desmond T, Frey K, Haroutunian V, Davis K, Watson S. 158. Decreased vesicular monoamine transporter density in schizophrenic prefrontal cortex Biological Psychiatry. 47: S48. DOI: 10.1016/S0006-3223(00)00420-0 |
0.312 |
|
| 1999 |
Davis KL, Mohs RC, Marin DB, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. Neuropeptide abnormalities in patients with early Alzheimer disease. Archives of General Psychiatry. 56: 981-7. PMID 10565496 DOI: 10.1001/Archpsyc.56.11.981 |
0.322 |
|
| 1999 |
Friedman JI, Adler DN, Davis KL. The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease. Biological Psychiatry. 46: 1243-52. PMID 10560029 DOI: 10.1016/S0006-3223(99)00232-2 |
0.368 |
|
| 1999 |
Friedman JI, Harvey PD, Kemether E, Byne W, Davis KL. Cognitive and functional changes with aging in schizophrenia. Biological Psychiatry. 46: 921-8. PMID 10509175 DOI: 10.1016/S0006-3223(99)00080-3 |
0.351 |
|
| 1999 |
Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease. Archives of Neurology. 56: 713-8. PMID 10369312 DOI: 10.1001/Archneur.56.6.713 |
0.319 |
|
| 1999 |
Green CR, Marin DB, Mohs RC, Schmeidler J, Aryan M, Fine E, Davis KL. The impact of behavioral impairment of functional ability in Alzheimer's disease. International Journal of Geriatric Psychiatry. 14: 307-16. PMID 10340193 DOI: 10.1002/(Sici)1099-1166(199904)14:4<307::Aid-Gps908>3.0.Co;2-E |
0.332 |
|
| 1999 |
Amin F, Silverman JM, Siever LJ, Smith CJ, Knott PJ, Davis KL. Genetic antecedents of dopamine dysfunction in schizophrenia. Biological Psychiatry. 45: 1143-50. PMID 10331106 DOI: 10.1016/S0006-3223(98)00262-5 |
0.349 |
|
| 1999 |
Davis KL, Mohs RC, Marin D, Purohit DP, Perl DP, Lantz M, Austin G, Haroutunian V. Cholinergic markers in elderly patients with early signs of Alzheimer disease. Jama. 281: 1401-6. PMID 10217056 DOI: 10.1001/Jama.281.15.1401 |
0.331 |
|
| 1999 |
Harvey PD, Parrella M, White L, Mohs RC, Davidson M, Davis KL. Convergence of cognitive and adaptive decline in late-life schizophrenia. Schizophrenia Research. 35: 77-84. PMID 9988843 DOI: 10.1016/S0920-9964(98)00109-1 |
0.351 |
|
| 1999 |
Harvey PD, Silverman JM, Mohs RC, Parrella M, White L, Powchik P, Davidson M, Davis KL. Cognitive decline in late-life schizophrenia: a longitudinal study of geriatric chronically hospitalized patients. Biological Psychiatry. 45: 32-40. PMID 9894573 DOI: 10.1016/S0006-3223(98)00273-X |
0.333 |
|
| 1999 |
Friedman JI, Temporini H, Davis KL. Pharmacologic strategies for augmenting cognitive performance in schizophrenia. Biological Psychiatry. 45: 1-16. PMID 9894570 DOI: 10.1016/S0006-3223(98)00287-X |
0.354 |
|
| 1998 |
Samuels SC, Davis KL. Experimental approaches to cognitive disturbance in Alzheimer's disease. Harvard Review of Psychiatry. 6: 11-22. PMID 10370429 DOI: 10.3109/10673229809010950 |
0.31 |
|
| 1998 |
Davis KL. "Ethical problems in psychiatric research". The Journal of Behavioral Health Services & Research. 25: 467; author reply 46. PMID 9796169 DOI: 10.1007/Bf02287518 |
0.319 |
|
| 1998 |
Powchik P, Davidson M, Haroutunian V, Gabriel SM, Purohit DP, Perl DP, Harvey PD, Davis KL. Postmortem studies in schizophrenia. Schizophrenia Bulletin. 24: 325-41. PMID 9718627 DOI: 10.1093/Oxfordjournals.Schbul.A033330 |
0.387 |
|
| 1998 |
Healy DJ, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ, Meador-Woodruff JH. AMPA receptor binding and subunit mRNA expression in prefrontal cortex and striatum of elderly schizophrenics. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 19: 278-86. PMID 9718591 DOI: 10.1016/S0893-133X(98)00014-1 |
0.312 |
|
| 1998 |
Harvey PD, Howanitz E, Parrella M, White L, Davidson M, Mohs RC, Hoblyn J, Davis KL. Symptoms, cognitive functioning, and adaptive skills in geriatric patients with lifelong schizophrenia: a comparison across treatment sites. The American Journal of Psychiatry. 155: 1080-6. PMID 9699697 DOI: 10.1176/Ajp.155.8.1080 |
0.351 |
|
| 1998 |
Byne W, White L, Parella M, Adams R, Harvey PD, Davis KL. Tardive dyskinesia in a chronically institutionalized population of elderly schizophrenic patients: prevalence and association with cognitive impairment. International Journal of Geriatric Psychiatry. 13: 473-9. PMID 9695037 DOI: 10.1002/(Sici)1099-1166(199807)13:7<473::Aid-Gps800>3.0.Co;2-Z |
0.306 |
|
| 1998 |
Davis KL, Buchsbaum MS, Shihabuddin L, Spiegel-Cohen J, Metzger M, Frecska E, Keefe RS, Powchik P. Ventricular enlargement in poor-outcome schizophrenia. Biological Psychiatry. 43: 783-93. PMID 9611667 DOI: 10.1016/S0006-3223(97)00553-2 |
0.511 |
|
| 1998 |
Gabriel SM, Marin DB, Aisen PS, Lantz M, Altstiel LD, Davis KL, Mohs RC. Association of elevated alpha 1-antichymotrypsin with cognitive impairment in a prospective study of the very old. The American Journal of Psychiatry. 155: 698-700. PMID 9585727 DOI: 10.1176/Ajp.155.5.698 |
0.457 |
|
| 1998 |
Purohit DP, Perl DP, Haroutunian V, Powchik P, Davidson M, Davis KL. Alzheimer disease and related neurodegenerative diseases in elderly patients with schizophrenia: a postmortem neuropathologic study of 100 cases. Archives of General Psychiatry. 55: 205-11. PMID 9510214 DOI: 10.1001/Archpsyc.55.3.205 |
0.409 |
|
| 1998 |
Silverman JM, Smith CJ, Guo SL, Mohs RC, Siever LJ, Davis KL. Lateral ventricular enlargement in schizophrenic probands and their siblings with schizophrenia-related disorders. Biological Psychiatry. 43: 97-106. PMID 9474442 DOI: 10.1016/S0006-3223(97)00247-3 |
0.353 |
|
| 1997 |
Meador-Woodruff JH, Haroutunian V, Powchik P, Davidson M, Davis KL, Watson SJ. Dopamine receptor transcript expression in striatum and prefrontal and occipital cortex. Focal abnormalities in orbitofrontal cortex in schizophrenia. Archives of General Psychiatry. 54: 1089-95. PMID 9400344 DOI: 10.1001/Archpsyc.1997.01830240045007 |
0.303 |
|
| 1997 |
Marin DB, Green CR, Schmeidler J, Harvey PD, Lawlor BA, Ryan TM, Aryan M, Davis KL, Mohs RC. Noncognitive disturbances in Alzheimer's disease: frequency, longitudinal course, and relationship to cognitive symptoms. Journal of the American Geriatrics Society. 45: 1331-8. PMID 9361658 DOI: 10.1111/J.1532-5415.1997.Tb02932.X |
0.315 |
|
| 1997 |
Gabriel SM, Haroutunian V, Powchik P, Honer WG, Davidson M, Davies P, Davis KL. Increased concentrations of presynaptic proteins in the cingulate cortex of subjects with schizophrenia. Archives of General Psychiatry. 54: 559-66. PMID 9193197 DOI: 10.1001/Archpsyc.1997.01830180077010 |
0.347 |
|
| 1997 |
Li G, Silverman JM, Smith CJ, Zaccario ML, Wentzel-Bell C, Siever LJ, Mohs RC, Davis KL. Validity of the family history method for identifying schizophrenia-related disorders. Psychiatry Research. 70: 39-48. PMID 9172275 DOI: 10.1016/S0165-1781(97)03120-X |
0.326 |
|
| 1997 |
Aisen PS, Davis KL. The search for disease-modifying treatment for Alzheimer's disease. Neurology. 48: S35-41. PMID 9153159 DOI: 10.1212/Wnl.48.5_Suppl_6.35S |
0.455 |
|
| 1997 |
Keefe RS, Silverman JM, Mohs RC, Siever LJ, Harvey PD, Friedman L, Roitman SE, DuPre RL, Smith CJ, Schmeidler J, Davis KL. Eye tracking, attention, and schizotypal symptoms in nonpsychotic relatives of patients with schizophrenia. Archives of General Psychiatry. 54: 169-76. PMID 9040285 DOI: 10.1001/Archpsyc.1997.01830140081014 |
0.543 |
|
| 1997 |
Buchsbaum M, Hazlett E, Shihabuddin L, Wei T, Haznedar M, Schnur D, Machac J, Vallabhajosula S, Knesaurek K, Mohs R, Davis K. Metabolic changes with age in schizophrenia Psychiatry Research: Neuroimaging. 68: 157. DOI: 10.1016/S0925-4927(97)81502-8 |
0.31 |
|
| 1996 |
Harvey PD, Davidson M, White L, Keefe RS, Hirschowitz J, Mohs RC, Davis KL. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale. Biological Psychiatry. 40: 755-60. PMID 8894068 DOI: 10.1016/0006-3223(95)00486-6 |
0.521 |
|
| 1996 |
Aisen PS, Marin D, Altstiel L, Goodwin C, Baruch B, Jacobson R, Ryan T, Davis KL. A pilot study of prednisone in Alzheimer's disease. Dementia (Basel, Switzerland). 7: 201-6. PMID 8835883 DOI: 10.1159/000106879 |
0.456 |
|
| 1996 |
Silverman JM, Greenberg DA, Altstiel LD, Siever LJ, Mohs RC, Smith CJ, Zhou G, Hollander TE, Yang XP, Kedache M, Li G, Zaccario ML, Davis KL. Evidence of a locus for schizophrenia and related disorders on the short arm of chromosome 5 in a large pedigree. American Journal of Medical Genetics. 67: 162-71. PMID 8723043 DOI: 10.1002/(Sici)1096-8628(19960409)67:2<162::Aid-Ajmg6>3.0.Co;2-U |
0.321 |
|
| 1996 |
Gabriel SM, Davidson M, Haroutunian V, Powchik P, Bierer LM, Purohit DP, Perl DP, Davis KL. Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biological Psychiatry. 39: 82-91. PMID 8717605 DOI: 10.1016/0006-3223(95)00066-6 |
0.378 |
|
| 1996 |
Serby M, Mohan C, Aryan M, Williams L, Mohs RC, Davis KL. Olfactory identification deficits in relatives of Alzheimer's disease patients. Biological Psychiatry. 39: 375-7. PMID 8704071 DOI: 10.1016/0006-3223(95)00472-6 |
0.312 |
|
| 1996 |
Keefe RS, Frescka E, Apter SH, Davidson M, Macaluso JM, Hirschowitz J, Davis KL. Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings. The American Journal of Psychiatry. 153: 806-11. PMID 8633694 DOI: 10.1176/Ajp.153.6.806 |
0.554 |
|
| 1996 |
Aisen PS, Marin D, Davis KL. Anti-inflammatory drug studies in Alzheimer's disease Biological Psychiatry. 39: 563. DOI: 10.1016/0006-3223(96)84163-1 |
0.433 |
|
| 1995 |
Marin DB, Bierer LM, Lawlor BA, Ryan TM, Jacobson R, Schmeidler J, Mohs RC, Davis KL. L-deprenyl and physostigmine for the treatment of Alzheimer's disease. Psychiatry Research. 58: 181-9. PMID 8570774 DOI: 10.1016/0165-1781(95)02714-8 |
0.302 |
|
| 1995 |
Keefe RS, Roitman SE, Harvey PD, Blum CS, DuPre RL, Prieto DM, Davidson M, Davis KL. A pen-and-paper human analogue of a monkey prefrontal cortex activation task: spatial working memory in patients with schizophrenia. Schizophrenia Research. 17: 25-33. PMID 8541247 DOI: 10.1016/0920-9964(95)00027-J |
0.509 |
|
| 1995 |
Lawlor BA, Bierer LM, Ryan TM, Schmeidler J, Knott PJ, Williams LL, Mohs RC, Davis KL. Plasma 3-methoxy-4-hydroxyphenylglycol (MHPG) and clinical symptoms in Alzheimer's disease. Biological Psychiatry. 38: 185-8. PMID 7578662 DOI: 10.1016/0006-3223(94)00259-6 |
0.333 |
|
| 1995 |
Siever LJ, Rotter M, Losonczy M, Guo SL, Mitropoulou V, Trestman R, Apter S, Zemishlany Z, Silver-man J, Horvath TB, Davidson M, Mohs R, Davis KL. Lateral ventricular enlargement in schizotypal personality disorder Psychiatry Research-Neuroimaging. 57: 109-118. PMID 7480378 DOI: 10.1016/0165-1781(95)02645-D |
0.347 |
|
| 1995 |
Aisen PS, Davis KL. Drs. Aisen and Davis Reply American Journal of Psychiatry. 152: 1242-1242. DOI: 10.1176/Ajp.152.8.1242 |
0.39 |
|
| 1995 |
Keefe RS, Lees Roitman S, Dupre RL, Harvey PD, Davis KL, Mohs RC. The relationship between working memory deficits and other measures sensitive to prefrontal dysfunction Schizophrenia Research. 15: 123. DOI: 10.1016/0920-9964(95)95378-M |
0.462 |
|
| 1995 |
Siever LJ, Trestman RL, Siegel BV, Losonczy M, Mitropoulou V, Silverman J, Keefe R, Mohs R, Buchsbaum M, Davis KL. Neuroimaging, neurobiological, and neuropsychological abnormalities in SPD: Implications for a model of the schizophrenia spectrum Schizophrenia Research. 15: 99. DOI: 10.1016/0920-9964(95)95307-U |
0.529 |
|
| 1995 |
Silverman JM, Shiabuddin L, Buchsbaum M, Altstiel LD, Greenberg DA, Smith CJ, Siever LJ, Mobs RC, Davis KL. A neuroimaging correlate for a schizophrenia-related genetic marker in one pedigree Schizophrenia Research. 15: 49. DOI: 10.1016/0920-9964(95)95158-6 |
0.32 |
|
| 1995 |
Golier JA, Silverman JM, Davidson M, Losonczy MF, Schmeidler J, Davis KL. A comparison of ventricular size in familial versus sporadic schizophrenia Schizophrenia Research. 15: 39. DOI: 10.1016/0920-9964(95)95127-U |
0.316 |
|
| 1995 |
Shihabuddin L, Silverman J, Buchsbaum M, Metzger M, Davis K. Neuroimaging correlates of genetic marker for schizophrenia Biological Psychiatry. 37: 662. DOI: 10.1016/0006-3223(95)94657-I |
0.305 |
|
| 1995 |
Silverman JM, Li G, Mohs RC, Davis KL. Risk of Alzheimer's Disease in First-Degree Relatives-Reply Archives of General Psychiatry. 52: 318-319. DOI: 10.1001/Archpsyc.1995.03950160068015 |
0.3 |
|
| 1994 |
Stern RG, Mohs RC, Davidson M, Schmeidler J, Silverman J, Kramer-Ginsberg E, Searcey T, Bierer L, Davis KL. A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration. The American Journal of Psychiatry. 151: 390-6. PMID 8109647 DOI: 10.1176/Ajp.151.3.390 |
0.31 |
|
| 1994 |
Haroutunian V, Davidson M, Kanof PD, Perl DP, Powchik P, Losonczy M, McCrystal J, Purohit DP, Bierer LM, Davis KL. Cortical cholinergic markers in schizophrenia. Schizophrenia Research. 12: 137-44. PMID 8043524 DOI: 10.1016/0920-9964(94)90071-X |
0.364 |
|
| 1994 |
Keefe RS, Silverman JM, Roitman SE, Harvey PD, Duncan MA, Alroy D, Siever LJ, Davis KL, Mohs RC. Performance of nonpsychotic relatives of schizophrenic patients on cognitive tests. Psychiatry Research. 53: 1-12. PMID 7991726 DOI: 10.1016/0165-1781(94)90091-4 |
0.527 |
|
| 1994 |
Bierer L, Aisen PS, Davidson M, Ryan TM, Schmeidler J, Davis KL. A pilot study of clonidine plus physostigmine in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 5: 243-246. PMID 7951680 DOI: 10.1159/000106731 |
0.48 |
|
| 1994 |
Aisen PS, Davis KL. Inflammatory mechanisms in Alzheimer's disease: Implications for therapy American Journal of Psychiatry. 151: 1105-1113. PMID 7518651 DOI: 10.1176/AJP.151.8.1105 |
0.376 |
|
| 1994 |
Kahn RS, Harvey PD, Davidson M, Keefe RS, Apter S, Neale JM, Mohs RC, Davis KL. Neuropsychological correlates of central monoamine function in chronic schizophrenia: relationship between CSF metabolites and cognitive function. Schizophrenia Research. 11: 217-24. PMID 7514887 DOI: 10.1016/0920-9964(94)90015-9 |
0.532 |
|
| 1994 |
Davis KL. Cholinesterase Inhibitors in Alzheimer's Disease Neuropsychopharmacology. 11: 258-258. DOI: 10.1038/Sj.Npp.1380115 |
0.312 |
|
| 1994 |
Frecska E, Losonczy M, Keefe R, Apter S, Davidson M, Mohs R, Davis K. Age dependent change of ventricular measures in schizophrenia: Cross-sectional analysis Biological Psychiatry. 35: 704-705. DOI: 10.1016/0006-3223(94)90980-6 |
0.426 |
|
| 1994 |
Apter S, Keefe R, Hirschowitz J, Davidson M, Macaluso J, Amato R, Davis K. Longitudinal classification in schizophrenia: The relationship between kraepelinian and deficit syndrome subtypologies Biological Psychiatry. 35: 695. DOI: 10.1016/0006-3223(94)90944-X |
0.456 |
|
| 1994 |
Keefe R, Blum C, Roitman S, Harvey P, Davidson M, Mohs R, Davis K. Working memory dysfunction in Kraepelinian schizophrenics Biological Psychiatry. 35: 660. DOI: 10.1016/0006-3223(94)90820-6 |
0.372 |
|
| 1993 |
Aisen PS, Bierer LM, Davidson M, Ryan TM, Kaminsky R, Davis KL. Response to Combination Cholinergic/Noradrenergic Treatments in a Patient With Alzheimer's Disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 1: 244-248. PMID 28530925 DOI: 10.1097/00019442-199300130-00009 |
0.487 |
|
| 1993 |
Green CR, Mohs RC, Schmeidler J, Aryan M, Davis KL. Functional decline in Alzheimer's disease: a longitudinal study. Journal of the American Geriatrics Society. 41: 654-61. PMID 8505464 DOI: 10.1111/J.1532-5415.1993.Tb06740.X |
0.311 |
|
| 1993 |
Davidson M, Kahn R, Stern RG, Hirschowitz J, Apter S, Knott P, Davis KL. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia Psychiatry Research-Neuroimaging. 46: 151-163. PMID 8483974 DOI: 10.1016/0165-1781(93)90017-B |
0.333 |
|
| 1993 |
Purohit DP, Davidson M, Perl DP, Powchik P, Haroutunian VH, Bierer LM, McCrystal J, Losonczy M, Davis KL. Severe cognitive impairment in elderly schizophrenic patients: a clinicopathological study. Biological Psychiatry. 33: 255-60. PMID 8471678 DOI: 10.1016/0006-3223(93)90291-K |
0.372 |
|
| 1993 |
Silverman JM, Siever LJ, Horvath TB, Coccaro EF, Klar H, Davidson M, Pinkham L, Apter SH, Mohs RC, Davis KL. Schizophrenia-related and affective personality disorder traits in relatives of probands with schizophrenia and personality disorders. The American Journal of Psychiatry. 150: 435-42. PMID 8434659 DOI: 10.1176/Ajp.150.3.435 |
0.314 |
|
| 1993 |
Bierer LM, Aisen PS, Davidson M, Ryan TM, Stern RG, Schmeidler J, Davis KL. A pilot study of oral physostigmine plus yohimbine in patients with Alzheimer disease. Alzheimer Disease & Associated Disorders. 7: 98-104. PMID 8347333 DOI: 10.1097/00002093-199307020-00005 |
0.493 |
|
| 1993 |
Bierer LM, Knott PJ, Schmeidler JM, Marin DB, Ryan TM, Haroutunian V, Purohit DP, Perl DP, Mohs RC, Davis KL. Post-mortem examination of dopaminergic parameters in Alzheimer's disease: relationship to noncognitive symptoms. Psychiatry Research. 49: 211-7. PMID 8177917 DOI: 10.1016/0165-1781(93)90062-L |
0.333 |
|
| 1993 |
Gabriel SM, Bierer LM, Harotunian V, Purohit DP, Perl DP, Davis KL. Widespread deficits in somatostatin but not neuropeptide Y concentrations in Alzheimer's disease cerebral cortex. Neuroscience Letters. 155: 116-20. PMID 8103205 DOI: 10.1016/0304-3940(93)90686-F |
0.303 |
|
| 1993 |
Kahn RS, Davidson M, Knott P, Stern RG, Apter S, Davis KL. Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment. Archives of General Psychiatry. 50: 599-605. PMID 7688208 DOI: 10.1001/Archpsyc.1993.01820200009001 |
0.3 |
|
| 1993 |
Frecska E, Losonczy M, Keefe R, Silverman J, Davidson M, Davis K. The characteristics of poor outcome, ‘Kraepelinian’ schizophrenia European Neuropsychopharmacology. 3: 400. DOI: 10.1016/0924-977X(93)90193-P |
0.443 |
|
| 1993 |
Keefe R, Lees S, Merhige D, Blum C, Harvey P, Davis K, Mohs R. Visuospatial working memory deficits in schizophrenia Schizophrenia Research. 9: 179-180. DOI: 10.1016/0920-9964(93)90355-M |
0.444 |
|
| 1992 |
Stern RG, Mohs RC, Bierer LM, Silverman JM, Schmeidler J, Davidson M, Davis KL. Deterioration on the Blessed test in Alzheimer's disease: longitudinal data and their implications for clinical trials and identification of subtypes. Psychiatry Research. 42: 101-10. PMID 1631247 DOI: 10.1016/0165-1781(92)90074-D |
0.312 |
|
| 1992 |
Keefe RS, Harvey PD, Lenzenweger MF, Davidson M, Apter SH, Schmeidler J, Mohs RC, Davis KL. Empirical assessment of the factorial structure of clinical symptoms in schizophrenia: negative symptoms. Psychiatry Research. 44: 153-65. PMID 1480680 DOI: 10.1016/0165-1781(92)90049-9 |
0.487 |
|
| 1992 |
Davis KL, Thal LJ, Gamzu ER, Davis CS, Woolson RF, Gracon SI, Drachman DA, Schneider LS, Whitehouse PJ, Hoover TM. A double-blind, placebo-controlled multicenter study of tacrine for Alzheimer's disease. The Tacrine Collaborative Study Group. The New England Journal of Medicine. 327: 1253-9. PMID 1406817 DOI: 10.1056/Nejm199210293271801 |
0.34 |
|
| 1992 |
Davidson M, Kahn RS, Stern RG, Harvey PD, Keefe R, Knott P, Apter S, Webster L, Davis KL. Measurements of plasma homovanillic acid in schizophrenic patients. Clinical Neuropharmacology. 521A-522A. PMID 1354058 DOI: 10.1097/00002826-199201001-00271 |
0.464 |
|
| 1992 |
Davidson M, Powchik P, Haroutunian V, Harvey PD, Perl D, Losonczy MS, Freske E, Bierer L, Mohs RC, Davis KL. DEMENTIA-LIKE SYMPTOMS IN ELDERLY SCHIZOPHRENIC PATIENTS Clinical Neuropharmacology. 15: 254B. DOI: 10.1097/00002826-199202001-00489 |
0.307 |
|
| 1992 |
Frecska E, Losonczy MF, Keefe RSE, Silverman JM, Davidson M, Davis KL. Characteristics Of Poor Outcome Schizophrenia Clinical Neuropharmacology. 15. DOI: 10.1097/00002826-199202001-00170 |
0.507 |
|
| 1991 |
Keefe RS, Lobel DS, Mohs RC, Silverman JM, Harvey PD, Davidson M, Losonczy MF, Davis KL. Diagnostic issues in chronic schizophrenia: kraepelinian schizophrenia, undifferentiated schizophrenia, and state-independent negative symptoms. Schizophrenia Research. 4: 71-9. PMID 2039764 DOI: 10.1016/0920-9964(91)90026-N |
0.546 |
|
| 1991 |
Harvey PD, Davidson M, Powchik P, Schmeidler J, McQueeney R, Kaminsky R, Davis KL. Time course and clinical predictors of treatment response in schizophrenia. Schizophrenia Research. 5: 161-6. PMID 1931808 DOI: 10.1016/0920-9964(91)90043-Q |
0.314 |
|
| 1991 |
Davidson M, Kahn RS, Knott P, Kaminsky R, Cooper M, DuMont K, Apter S, Davis KL. Effects of neuroleptic treatment on symptoms of schizophrenia and plasma homovanillic acid concentrations. Archives of General Psychiatry. 48: 910-3. PMID 1929760 DOI: 10.1001/Archpsyc.1991.01810340042005 |
0.325 |
|
| 1991 |
Davis KL, Kahn RS, Ko G, Davidson M. Dopamine in schizophrenia: a review and reconceptualization. The American Journal of Psychiatry. 148: 1474-86. PMID 1681750 DOI: 10.1176/Ajp.148.11.1474 |
0.34 |
|
| 1991 |
Davidson M, Kahn RS, Powchik P, Warne P, Losonczy MF, Kaminsky R, Apter S, Jaff S, Davis KL. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation. Archives of General Psychiatry. 48: 73-6. PMID 1670618 DOI: 10.1001/Archpsyc.1991.01810250075011 |
0.31 |
|
| 1991 |
Kahn R, Davidson M, Gabriel S, DuMont K, Dubie C, Moore C, Apter S, Siever L, Davis K. Serotonin receptor sensitivity in schizophrenia Schizophrenia Research. 4: 347-348. DOI: 10.1016/0920-9964(91)90262-P |
0.321 |
|
| 1991 |
Frecska E, Losonczy M, Keefe R, Silverman J, Davidson M, Harvey P, McQueeney R, Lobel D, Apter S, Davis K. Kraepelinian schizophrenia: A replication in an independent sample Schizophrenia Research. 4: 257. DOI: 10.1016/0920-9964(91)90108-4 |
0.446 |
|
| 1990 |
Davidson M, Harvey PD, Bergman RL, Powchik P, Kaminsky R, Losonczy MF, Davis KL. Effects of the D-1 agonist SKF-38393 combined with haloperidol in schizophrenic patients. Archives of General Psychiatry. 47: 190-1. PMID 2405808 DOI: 10.1001/Archpsyc.1990.01810140090014 |
0.323 |
|
| 1990 |
Siever LJ, Silverman JM, Horvath TB, Klar H, Coccaro E, Keefe RS, Pinkham L, Rinaldi P, Mohs RC, Davis KL. Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients. Archives of General Psychiatry. 47: 634-40. PMID 2360857 DOI: 10.1001/Archpsyc.1990.01810190034005 |
0.508 |
|
| 1990 |
Harvey PD, Keefe RS, Moskowitz J, Putnam KM, Mohs RC, Davis KL. Attentional markers of vulnerability to schizophrenia: performance of medicated and unmedicated patients and normals. Psychiatry Research. 33: 179-88. PMID 2243895 DOI: 10.1016/0165-1781(90)90072-D |
0.496 |
|
| 1989 |
Keefe RS, Mohs RC, Losonczy MF, Davidson M, Silverman JM, Horvath TB, Davis KL. Premorbid sociosexual functioning and long-term outcome in schizophrenia. The American Journal of Psychiatry. 146: 206-11. PMID 2912262 DOI: 10.1176/AJP.146.2.206 |
0.463 |
|
| 1989 |
Keefe RS, Siever LJ, Mohs RC, Peterson AE, Mahon TR, Bergman RL, Davis KL. Eye tracking, schizophrenic symptoms, and schizotypal personality disorder. European Archives of Psychiatry and Neurological Sciences. 239: 39-42. PMID 2792157 DOI: 10.1007/BF01739742 |
0.429 |
|
| 1989 |
Kanof PD, Coccaro EF, Johns CA, Davidson M, Siever LJ, Davis KL. Cyclic-AMP production by polymorphonuclear leukocytes in psychiatric disorders. Biological Psychiatry. 25: 413-20. PMID 2539205 DOI: 10.1016/0006-3223(89)90194-7 |
0.323 |
|
| 1989 |
Davidson M, Bierer LM, Kaminsky R, Ryan TM, Davis KL. Combined administration of physostigmine and clonidine to patients with dementia of the Alzheimer type: a pilot safety study. Alzheimer Disease & Associated Disorders. 3: 224-227. DOI: 10.1097/00002093-198900000-00005 |
0.317 |
|
| 1989 |
Silverman JM, Keefe RSE, Mohs RC, Davis KL. A study of the reliability of the family history method in genetic studies of Alzheimer disease. Alzheimer Disease & Associated Disorders. 3: 218-223. DOI: 10.1097/00002093-198900000-00004 |
0.477 |
|
| 1989 |
Harvey PD, Jaff S, Davidson M, Davis KL. Effects of D1 agonist in schizophrenia Biological Psychiatry. 25: A170-A171. DOI: 10.1016/0006-3223(89)91831-3 |
0.321 |
|
| 1989 |
Silverman JM, Mohs RC, Siever LJ, Keefe RSE, Schear S, Davis KL. Using family history screening for linkage studies in schizophrenia Biological Psychiatry. 25. DOI: 10.1016/0006-3223(89)91776-9 |
0.499 |
|
| 1989 |
Siever LJ, Coccaro EF, Silverman J, Keefe R, Klar H, Davis KL. Biologic markers for personality disorders: A dimensional approach Biological Psychiatry. 25: A140. DOI: 10.1016/0006-3223(89)91769-1 |
0.433 |
|
| 1989 |
Keefe RS, Harvey PD, Bergman R, Mohs RC, Davis KL. State and trait components of negative symptoms within schizophrenic patients Biological Psychiatry. 25: A105. DOI: 10.1016/0006-3223(89)91698-3 |
0.474 |
|
| 1989 |
Keefe RSE, Siever LJ, Silverman JM, Mohs RC, Davis KL. symptom correlates of poor eye tracking in patients with schizotypal personality disorder and relatives of schizophrenic probands Biological Psychiatry. 25. DOI: 10.1016/0006-3223(89)91693-4 |
0.48 |
|
| 1989 |
Keefe RSE, Mohs RC, Siever LJ, Silverman JM, Harvey PD, Brenin DS, Davis KL. Relations among eye tracking, CPT, and backward masking deficits in schizophrenic patients and their relatives Biological Psychiatry. 25. DOI: 10.1016/0006-3223(89)91692-2 |
0.469 |
|
| 1989 |
Lobel D, Horvath T, Mohs RC, Davis KL. A reexamination of schizophrenia subtypes Biological Psychiatry. 25. DOI: 10.1016/0006-3223(89)91680-6 |
0.341 |
|
| 1989 |
Harvey PD, Davidson M, Runyon N, Davis KL. Time course and clinical predictors of neuroleptic response in schizophrenia Biological Psychiatry. 25: A17. DOI: 10.1016/0006-3223(89)91521-7 |
0.326 |
|
| 1988 |
Davidson M, Davis KL. A Comparison of Plasma Homovanillic Acid Concentrations in Schizophrenic Patients and Normal Controls Archives of General Psychiatry. 45: 561-563. PMID 3377642 DOI: 10.1001/Archpsyc.1988.01800300057006 |
0.319 |
|
| 1988 |
Davidson M, Zemishlany Z, Mohs RC, Horvath TB, Powchik P, Blass JP, Davis KL. 4-Aminopyridine in the treatment of Alzheimer's disease. Biological Psychiatry. 23: 485-90. PMID 2830918 DOI: 10.1016/0006-3223(88)90020-0 |
0.323 |
|
| 1988 |
Davidson M, Bastiaens L, Davis BM, Shah MB, Davis KL. Endocrine Changes in Alzheimer’s Disease Endocrinology and Metabolism Clinics of North America. 17: 149-157. DOI: 10.1016/S0889-8529(18)30438-9 |
0.319 |
|
| 1988 |
Davidson M, Bastiaens L, Davis BM, Shah MB, Davis KL. Endocrine changes in Alzheimer's disease. Neurologic Clinics. 6: 149-157. DOI: 10.1016/S0733-8619(18)30889-2 |
0.326 |
|
| 1987 |
Silverman JM, Mohs RC, Davidson M, Losonczy MF, Keefe RS, Breitner JC, Sorokin JE, Davis KL. Familial schizophrenia and treatment response. The American Journal of Psychiatry. 144: 1271-6. PMID 3661762 DOI: 10.1176/Ajp.144.10.1271 |
0.547 |
|
| 1987 |
Hollander E, Davidson M, Mohs RC, Horvath TB, Davis BM, Zemishlany Z, Davis KL. RS 86 in the treatment of Alzheimer's disease: cognitive and biological effects. Biological Psychiatry. 22: 1067-78. PMID 3651528 DOI: 10.1016/0006-3223(87)90049-7 |
0.313 |
|
| 1987 |
Keefe RS, Mohs RC, Losonczy MF, Davidson M, Silverman JM, Kendler KS, Horvath TB, Nora R, Davis KL. Characteristics of very poor outcome schizophrenia. The American Journal of Psychiatry. 144: 889-95. PMID 3605400 DOI: 10.1176/Ajp.144.7.889 |
0.556 |
|
| 1987 |
Mohs RC, Breitner JC, Silverman JM, Davis KL. Alzheimer's disease. Morbid risk among first-degree relatives approximates 50% by 90 years of age. Archives of General Psychiatry. 44: 405-8. PMID 3579492 DOI: 10.1001/Archpsyc.1987.01800170019003 |
0.302 |
|
| 1987 |
Davidson M, Keefe RS, Mohs RC, Siever LJ, Losonczy MF, Horvath TB, Davis KL. L-dopa challenge and relapse in schizophrenia. The American Journal of Psychiatry. 144: 934-8. PMID 2886063 DOI: 10.1176/AJP.144.7.934 |
0.42 |
|
| 1987 |
Kanof PD, Davidson M, Johns CA, Mohs RC, Davis KL. Clinical correlates of platelet prostaglandin receptor subsensitivity in schizophrenia. The American Journal of Psychiatry. 144: 1556-60. PMID 2825548 DOI: 10.1176/Ajp.144.12.1556 |
0.323 |
|
| 1986 |
Davis KL, Davis BM, Greenwald BS, Mohs RC, Mathé AA, Johns CA, Horvath TB. Cortisol and Alzheimer's disease, I: Basal studies. The American Journal of Psychiatry. 143: 300-5. PMID 3953862 DOI: 10.1176/Ajp.143.3.300 |
0.305 |
|
| 1986 |
Losonczy MF, Song IS, Mohs RC, Small NA, Davidson M, Johns CA, Davis KL. Correlates of lateral ventricular size in chronic schizophrenia, I: Behavioral and treatment response measures. The American Journal of Psychiatry. 143: 976-81. PMID 3524278 DOI: 10.1176/Ajp.143.8.976 |
0.362 |
|
| 1986 |
Haroutunian V, Kanof PD, Tsuboyama GK, Campbell GA, Davis KL. Animal models of Alzheimer's disease: behavior, pharmacology, transplants. The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques. 13: 385-93. PMID 2878711 DOI: 10.1017/S0317167100036957 |
0.331 |
|
| 1986 |
Davis KL, Fiori M, Davis BM, Mohs RC, Horvath TB, Davidson M. Dopaminergic dysregulation in schizophrenia: A target for new drugs Drug Development Research. 9: 71-83. DOI: 10.1002/Ddr.430090109 |
0.348 |
|
| 1985 |
Kendler KS, Masterson CC, Davis KL. Psychiatric illness in first-degree relatives of patients with paranoid psychosis, schizophrenia and medical illness British Journal of Psychiatry. 147: 524-531. PMID 4075047 DOI: 10.1192/Bjp.147.5.524 |
0.345 |
|
| 1985 |
Greenwald BS, Edasery J, Mohs RC, Shah N, Trigos GG, Davis KL. Red blood cell choline. I: Choline in Alzheimer's disease. Biological Psychiatry. 20: 367-74. PMID 3978170 DOI: 10.1016/0006-3223(85)90039-3 |
0.304 |
|
| 1985 |
Davis BM, Davis KL, Mohs RC, Mathé AA, Rothpearl AB, Johns CA, Levy MI, Horvath TB. Evaluating prolactin response to dopamine agonists in schizophrenia. Methodological problems. Archives of General Psychiatry. 42: 259-64. PMID 3977547 DOI: 10.1001/Archpsyc.1985.01790260053006 |
0.307 |
|
| 1985 |
Davis KL, Davidson M, Mohs RC, Kendler KS, Davis BM, Johns CA, DeNigris Y, Horvath TB. Plasma homovanillic acid concentration and the severity of schizophrenic illness. Science (New York, N.Y.). 227: 1601-2. PMID 3975630 DOI: 10.1126/Science.3975630 |
0.312 |
|
| 1985 |
Mohs RC, Davis BM, Johns CA, Mathé AA, Greenwald BS, Horvath TB, Davis KL. Oral physostigmine treatment of patients with Alzheimer's disease. The American Journal of Psychiatry. 142: 28-33. PMID 3881051 DOI: 10.1176/Ajp.142.1.28 |
0.311 |
|
| 1985 |
Mohs RC, Davis BM, Greenwald BS, Mathé AA, Johns CA, Horvath TB, Davis KL. Clinical studies of the cholinergic deficit in Alzheimer's disease. II. Psychopharmacologic studies. Journal of the American Geriatrics Society. 33: 749-57. PMID 2865282 DOI: 10.1111/J.1532-5415.1985.Tb04185.X |
0.346 |
|
| 1985 |
Davis BM, Mohs RC, Greenwald BS, Mathé AA, Johns CA, Horvath TB, Davis KL. Clinical studies of the cholinergic deficit in Alzheimer's disease. I. Neurochemical and neuroendocrine studies. Journal of the American Geriatrics Society. 33: 741-8. PMID 2414354 DOI: 10.1111/J.1532-5415.1985.Tb04184.X |
0.333 |
|
| 1984 |
Rosen WG, Mohs RC, Johns CA, Small NS, Kendler KS, Horvath TB, Davis KL. Positive and negative symptoms in schizophrenia. Psychiatry Research. 13: 277-84. PMID 6596585 DOI: 10.1016/0165-1781(84)90075-1 |
0.332 |
|
| 1984 |
Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. The American Journal of Psychiatry. 141: 1356-64. PMID 6496779 DOI: 10.1176/Ajp.141.11.1356 |
0.3 |
|
| 1984 |
Levy MI, Davis BM, Mohs RC, Kendler KS, Mathé AA, Trigos G, Horvath TB, Davis KL. Apomorphine and schizophrenia. Treatment, CSF, and neuroendocrine responses. Archives of General Psychiatry. 41: 520-4. PMID 6372737 DOI: 10.1001/Archpsyc.1984.01790160106014 |
0.351 |
|
| 1984 |
Losonczy MF, Mohs RC, Davis KL. Seasonal variations of human lumbar CSF neurotransmitter metabolite concentrations. Psychiatry Research. 12: 79-87. PMID 6205414 DOI: 10.1016/0165-1781(84)90140-9 |
0.312 |
|
| 1984 |
Davis KL, Mohs RC, Horvath TB. The Schizophrenia Biologic Research Centers of the Veterans Administration Psychiatric Annals. 14: 269-271. DOI: 10.3928/0048-5713-19840401-10 |
0.327 |
|
| 1983 |
Deutsch SI, Davis KL. Schizophrenia: A review of diagnostic and biological issues. I. Diagnosis and prognosis Hospital and Community Psychiatry. 34: 313-322. PMID 6840719 DOI: 10.1176/Ps.34.4.313 |
0.335 |
|
| 1983 |
Levy MI, Davis BM, Mohs RC, Trigos GC, Mathé AA, Davis KL. Gamma-hydroxybutyrate in the treatment of schizophrenia. Psychiatry Research. 9: 1-8. PMID 6193548 DOI: 10.1016/0165-1781(83)90082-3 |
0.332 |
|
| 1983 |
Deutsch SI, Davis KL. Schizophrenia: A review of diagnostic and biological issues. II. Biological issues Hospital and Community Psychiatry. 34: 423-437. PMID 6133830 DOI: 10.1176/Ps.34.5.423 |
0.341 |
|
| 1983 |
Greenwald BS, Mohs RC, Davis KL. Neurotransmitter deficits in Alzheimer's disease: criteria for significance. Journal of the American Geriatrics Society. 31: 310-6. PMID 6132940 DOI: 10.1111/J.1532-5415.1983.Tb04877.X |
0.328 |
|
| 1982 |
Rosenberg GS, Davis KL. The use of cholinergic precursors in neuropsychiatric diseases American Journal of Clinical Nutrition. 36: 709-720. PMID 6214943 DOI: 10.1093/Ajcn/36.4.709 |
0.357 |
|
| 1981 |
Kendler KS, Davis KL. The genetics and biochemistry of paranoid schizophrenia and other paranoid psychosis Schizophrenia Bulletin. 7: 689-709. PMID 7034192 DOI: 10.1093/Schbul/7.4.689 |
0.353 |
|
| 1980 |
Berger PA, Faull KF, Kilkowski J, Anderson PJ, Kraemer H, Davis KL, Barchas JD. CSF monoamine metabolites in depression and schizophrenia American Journal of Psychiatry. 137: 174-180. PMID 7352572 DOI: 10.1176/Ajp.137.2.174 |
0.312 |
|
| 1979 |
Davis KL, Hollister LE, Livesey J, Berger PA. Cerebrospinal fluid acetylcholinesterase in neuropsychiatric disorders. Psychopharmacology. 63: 155-9. PMID 157494 DOI: 10.1007/Bf00429695 |
0.318 |
|
| 1978 |
Davis KL, Yamamura HI. Cholinergic underactivity in human memory disorders Life Sciences. 23: 1729-1733. PMID 364228 DOI: 10.1016/0024-3205(78)90100-5 |
0.304 |
|
| 1978 |
Davis KL, Berger PA, Hollister LE, Barchas JD. Cholinergic involvement in mental disorders. Life Sciences. 22: 1865-71. PMID 27686 DOI: 10.1016/0024-3205(78)90472-1 |
0.341 |
|
| 1976 |
Davis KL, Hollister LE, Barchas JD, Berger PA. Choline in tardive dyskinesia and Huntington's disease. Life Sciences. 19: 1507-15. PMID 136581 DOI: 10.1016/0024-3205(76)90095-3 |
0.303 |
|
| 1976 |
Davis KL, Hollister LE, Berger PA. Letter: Bacloffen in schizophrenia. Lancet. 1: 1245. PMID 58291 DOI: 10.1016/S0140-6736(76)92198-X |
0.337 |
|
| 1973 |
Shopsin B, Wilk S, Gershon S, Davis K, Suhl M. Cerebrospinal Fluid MHPG: An Assessment of Norepinephrine Metabolism in Affective Disorders Archives of General Psychiatry. 28: 230-233. PMID 4684289 DOI: 10.1001/Archpsyc.1973.01750320062010 |
0.309 |
|
| Show low-probability matches. |
